Eli Lilly to acquire Seattle-area vaccine maker for $1.5 billion - The Seattle Times

As reported by The Seattle Times

The acquisition of Curevo Vaccine, which develops vaccines for shingles and chickenpox, was announced Tuesday.

▸ MARKET SAMACHAR VIEW

NEUTRAL

Read full article on The Seattle Times ↗

Market Samachar is a news aggregator. This article was originally published by The Seattle Times. Tap the button above to read the full story on their site.

INDIAN Wall Street pushes to more records as profits keep piling up for US companies Markets-Economic Times
COMPANIES Ahead of Market: 10 things that will decide stock market action on Friday Stocks-Markets-Economic Times
INDIAN Nebius shares jump as former OpenAI employee's fund buys stake Markets-Economic Times
INDIAN Global Stocks: Europe's E6 states seek common position on capital market supervision Markets-Economic Times
INDIAN Apex Service sells minority stake to Apollo at $10 billion valuation, source says Markets-Economic Times
INDIAN Fed's Williams: Productivity shifts hard to spot in real time Markets-Economic Times
INDIAN Ashiana Housing Q4 profit flat at Rs 21 cr, revenue rises to Rs 335 cr Markets-Economic Times
INDIAN NorthWind Estates buys 5acre land in Yamuna Expressway region for Rs 189 cr via auction Markets-Economic Times

Eli Lilly to acquire Seattle-area vaccine maker for $1.5 billion - The Seattle Times

More from Market Samachar